Cargando…
Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19
The clinical spectrum of coronavirus disease 2019 (COVID-19) is still not fully understood. Cancer patients are uniquely vulnerable to COVID-19, and many have been or will be infected. Although an unfortunate minority will die from the infection, most will recover. This poses a challenge in which cl...
Autores principales: | Reidy-Lagunes, Diane, Saltz, Leonard, Postow, , Michael, Scordo, , Michael, Moskowitz, Alison, Tew, William, Zamarin, Dmitriy, Redelman-Sidi, Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454724/ https://www.ncbi.nlm.nih.gov/pubmed/32797188 http://dx.doi.org/10.1093/jnci/djaa111 |
Ejemplares similares
-
Ensuring equity in the era of HLA-restricted cancer therapeutics
por: Smithy, James W, et al.
Publicado: (2022) -
Could BCG be used to protect against COVID-19?
por: Redelman-Sidi, Gil
Publicado: (2020) -
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
por: Oseledchyk, Anton, et al.
Publicado: (2018) -
BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022) -
Monkeypox during COVID-19 era in Africa: Current challenges and recommendations
por: Okonji, Osaretin Christabel, et al.
Publicado: (2022)